Will AMDA stock price go up or down on Mon, 17 Jun 2019?


Amedica Corporation Forecast and Stock Analysis

Technical AMDA stock analysis for Friday June 14, 2019.

Sell candidate since 2019-06-05 Loss -26.13%

Amedica Corporation fell by -0.75% in the last day ( Friday, 14th Jun 2019 ) from $0.12 to $0.12 and has now fallen 4 days in a row. During day the stock fluctuated 7.76% from a day low at $0.12 to a day high of $0.13. The price has fallen in 7 of the last 10 days and is down by -32% for this period. Volume fell in the last day along with the stock, which is actually a good sign as volume should follow the stock. In the last day the trading volume fell by -0.53 million shares and in total 6.15 million shares bought and sold for approximately $731 414.00.

Quick summary:

  • 30 day high of the AMDA stock price was $0.23 and low was $0.11.
  • 90 day high was $0.25 and low was $0.11.
  • 52 week high for the Amedica Corporation - $1.17 and low - $0.11.


Amedica Corporation has broken the very wide and falling short-term trend down. Firstly a stronger fallrate is indicated, but false breaks and "sell-off" may occur. However, a further fall is realistic and any reactions back to the breaking point ($0.13) are considered to be a "second chance" to get out. According to the fan-theory $0.06 will represent the new bottom line of the next trend, but it is far too early to say this for certain.

Click here for today's Top 5 Trending Companies


There are few to none technical positive signals at the moment. Amedica Corporation holds sales signals from both short- and long-term moving averages. In addition, there is a general sales signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up there will be some resistance from the lines at $0.14 and $0.18. A break-up above any of these levels will issue buy signals. A sales signal was issued from a pivot top point on Tuesday June 04, 2019, which indicates further falls until a new bottom pivot has been found. Volume fell along with the price during the last trading day, which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk.

Access today's Top 5 Golden Star Companies

A sell signal from a double bottom formation was found on Tuesday June 04, 2019 with a target of $0.18. Despite the objective of the signal formation has been reached the stock may continue to fall.

Relative Strength Index (RSI)

The stock currently holds a RSI14 at 20 and is oversold on RSI14. The stock being oversold is no guarantee for instant reaction up as some stocks may be oversold for a long time. It is important to review the previous RSI-history to get an indication of the RSI-sensitiveness.

Access full RSI 14 and RSI 21 lists

Support & Resistance

There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.

Price: $0.12 Resistance: $0.12


This stock may move much during a day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0.01 between high and low, or 7.76%. For the last week the stock has had a daily average volatility of 25.23%.

Amedica Corporation is oversold on RSI14 (20). Some stocks may drop long and hard while being oversold on RSI before turning, which increases the general risk.

Our recommended stoploss: We hold a sell evaluation for this stock. No stop-loss set.

25.23 %

Average volatility

Overall risk:

Very Low Low Medium High Very High


Amedica Corporation holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Strong Sell Candidate Upgraded
Stronger Sell Today AMDA ranks #5259 as SELL CANDIDATE #5259 Weaker Sell

Will AMDA stock price go up or down on Mon, 17 Jun 2019?


Proudly made at

Rise Vilnius
in partnership with
Barclays Bank